Follow the Gland Pharma stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €468bn. The latest transaction was disclosed on 3 August 2026 (Disposal). Among the most active insiders: Jayatheerth Advani. All data is free.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€109,578
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Gland Pharma Buy (bullish), based on 14 analysts. Average price target: ₹2,856.07.
10Σ signal
Buys n/a€109,578 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,194 of 29,062 companies
57.4
score / 100
Value
36
Quality
79
FCF yld1.1%
Earn yld2.2%
EV/EBITDA24.8x
ROE11%
Gross mgn65%
Net mgn16%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.